4//SEC Filing
Lin Celia 4
Accession 0001209191-23-047105
CIK 0001831828other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 5:59 PM ET
Size
5.3 KB
Accession
0001209191-23-047105
Insider Transaction Report
Form 4
Lin Celia
Chief Medical Officer
Transactions
- Sale
Class A Common Stock
2023-08-21$16.65/sh−1,490$24,816→ 11,010 total
Footnotes (2)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on September 9, 2022.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.83, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001859386
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 5:59 PM ET
- Size
- 5.3 KB